{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:24:09Z","timestamp":1792801449630,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["31003A-132992"],"award-info":[{"award-number":["31003A-132992"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.bcp.2020.113860","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T20:39:18Z","timestamp":1583786358000},"page":"113860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Valproic acid affects fatty acid and triglyceride metabolism in HepaRG cells exposed to fatty acids by different mechanisms"],"prefix":"10.1016","volume":"177","author":[{"given":"David","family":"Gr\u00fcnig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonora","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Marbet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8347-4145","authenticated-orcid":false,"given":"Stephan","family":"Kr\u00e4henb\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2020.113860_b0005","first-page":"385","article-title":"On the propyl derivatives and decomposition products of ethylacetoacetate","volume":"3","author":"Burton","year":"1882","journal-title":"Am. Chem. J."},{"issue":"1 Suppl 1","key":"10.1016\/j.bcp.2020.113860_b0010","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1097\/00004714-200002001-00001","article-title":"Comprehensive review of the psychiatric uses of valproate","volume":"20","author":"Davis","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2020.113860_b0015","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1172\/JCI114877","article-title":"Inactivation of beef brain alpha-ketoglutarate dehydrogenase complex by valproic acid and valproic acid metabolites. Possible mechanism of anticonvulsant and toxic actions","volume":"86","author":"Luder","year":"1990","journal-title":"J. Clin. Investig."},{"issue":"2\u20133","key":"10.1016\/j.bcp.2020.113860_b0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0197-0186(00)00013-9","article-title":"Mechanisms of action of valproate: a commentatory","volume":"37","author":"Johannessen","year":"2000","journal-title":"Neurochem Int"},{"issue":"2","key":"10.1016\/j.bcp.2020.113860_b0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","article-title":"Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review","volume":"31","author":"Silva","year":"2008","journal-title":"J. Inherit. Metabol. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2020.113860_b0030","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0022-3565(24)37076-4","article-title":"Human CYP2C9 and CYP2A6 mediate formation of the hepatotoxin 4-ene-valproic acid","volume":"283","author":"Sadeque","year":"1997","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"2","key":"10.1016\/j.bcp.2020.113860_b0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0003-9861(83)90602-1","article-title":"Influence of valproic acid on hepatic carbohydrate and lipid metabolism","volume":"223","author":"Becker","year":"1983","journal-title":"Arch. Biochem. Biophys."},{"issue":"11","key":"10.1016\/j.bcp.2020.113860_b0040","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/0006-2952(92)90324-C","article-title":"In vitro effects of valproate and valproate metabolites on mitochondrial oxidations. Relevance of CoA sequestration to the observed inhibitions","volume":"43","author":"Ponchaut","year":"1992","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2020.113860_b0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0009-2797(01)00234-4","article-title":"Differential effect of valproate and its Delta2- and Delta4-unsaturated metabolites, on the beta-oxidation rate of long-chain and medium-chain fatty acids","volume":"137","author":"Silva","year":"2001","journal-title":"Chemico-Biol. Interact."},{"issue":"3","key":"10.1016\/j.bcp.2020.113860_b0050","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1212\/WNL.37.3.379","article-title":"Valproic acid hepatic fatalities: a retrospective review","volume":"37","author":"Dreifuss","year":"1987","journal-title":"Neurology"},{"issue":"8529","key":"10.1016\/j.bcp.2020.113860_b0055","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(87)91767-3","article-title":"Valproate hepatotoxicity","volume":"1","author":"Scheffner","year":"1987","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bcp.2020.113860_b0060","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hep.1840020513","article-title":"Valproate-induced hepatic injury: analyses of 23 fatal cases","volume":"2","author":"Zimmerman","year":"1982","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"4","key":"10.1016\/j.bcp.2020.113860_b0065","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1034\/j.1600-0676.2000.020004346.x","article-title":"Mitochondrial diseases represent a risk factor for valproate-induced fulminant liver failure","volume":"20","author":"Krahenbuhl","year":"2000","journal-title":"Liver"},{"issue":"5","key":"10.1016\/j.bcp.2020.113860_b0070","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/hep.23891","article-title":"Polymerase gamma gene POLG determines the risk of sodium valproate-induced liver toxicity","volume":"52","author":"Stewart","year":"2010","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1","key":"10.1016\/j.bcp.2020.113860_b0075","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/gut.37.1.140","article-title":"Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal, valproate induced hepatotoxicity","volume":"37","author":"Krahenbuhl","year":"1995","journal-title":"Gut"},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2020.113860_b0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0168-8278(97)82328-8","article-title":"Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation","volume":"26","author":"Fromenty","year":"1997","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.bcp.2020.113860_b0085","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.4254\/wjh.v7.i9.1251","article-title":"Valproic acid and nonalcoholic fatty liver disease: a possible association?","volume":"7","author":"Farinelli","year":"2015","journal-title":"World J. Hepatol."},{"issue":"2","key":"10.1016\/j.bcp.2020.113860_b0090","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.yebeh.2010.12.012","article-title":"Nonalcoholic fatty liver disease in adolescents receiving valproic acid","volume":"20","author":"Verrotti","year":"2011","journal-title":"Epilep. Behav."},{"issue":"1","key":"10.1016\/j.bcp.2020.113860_b0095","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eplepsyres.2009.04.004","article-title":"Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment","volume":"86","author":"Luef","year":"2009","journal-title":"Epilep. Res."},{"issue":"5","key":"10.1016\/j.bcp.2020.113860_b0100","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.bcp.2009.10.011","article-title":"Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis","volume":"79","author":"Aires","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2020.113860_b0105","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/FTD.0b013e3182608e2f","article-title":"Effect of short- and long-term treatment with valproate on carnitine homeostasis in humans","volume":"34","author":"Morand","year":"2012","journal-title":"Therapeut. Drug Monitor."},{"issue":"2","key":"10.1016\/j.bcp.2020.113860_b0110","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1124\/jpet.107.131185","article-title":"Toxicity of valproic acid in mice with decreased plasma and tissue carnitine stores","volume":"324","author":"Knapp","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"6","key":"10.1016\/j.bcp.2020.113860_b0115","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/hep.1840040609","article-title":"The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies","volume":"4","author":"Kesterson","year":"1984","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.bcp.2020.113860_b0120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.taap.2017.03.022","article-title":"Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis","volume":"324","author":"Bai","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2020.113860_b0125","doi-asserted-by":"crossref","first-page":"9576503","DOI":"10.1155\/2016\/9576503","article-title":"Study of Valproic Acid-Enhanced Hepatocyte Steatosis","volume":"2016","author":"Chang","year":"2016","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.bcp.2020.113860_b0130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.tiv.2017.05.013","article-title":"The catechol-O-methyltransferase inhibitors tolcapone and entacapone uncouple and inhibit the mitochondrial respiratory chain in HepaRG cells","volume":"42","author":"Grunig","year":"2017","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.bcp.2020.113860_b0135","doi-asserted-by":"crossref","DOI":"10.1093\/toxsci\/kfy101","article-title":"Effect of the catechol-O-methyltransferase inhibitors tolcapone and entacapone on fatty acid metabolism in HepaRG cells","author":"Grunig","year":"2018","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2020.113860_b0140","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cbi.2006.12.003","article-title":"The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics","volume":"168","author":"Guillouzo","year":"2007","journal-title":"Chemico-Biol. Interact."},{"issue":"3","key":"10.1016\/j.bcp.2020.113860_b0145","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1124\/dmd.109.030197","article-title":"Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells","volume":"38","author":"Antherieu","year":"2010","journal-title":"Drug Metabol. Disposit. Biol. Fate Chem."},{"key":"10.1016\/j.bcp.2020.113860_b0150","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3389\/fphar.2016.00443","article-title":"Comparison of liver cell models using the basel phenotyping cocktail","volume":"7","author":"Berger","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2020.113860_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2014.06.017","article-title":"Nicotine, cotinine, and beta-nicotyrine inhibit NNK-induced DNA-strand break in the hepatic cell line HepaRG","author":"Ordonez","year":"2014","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.bcp.2020.113860_b0160","doi-asserted-by":"crossref","unstructured":"D. Gr\u00fcnig, U. Duthaler, S. Krahenbuhl, Effect of toxicants on fatty acid metabolism in HepG2 cells, Front. Pharmacol., 2018 in press.","DOI":"10.3389\/fphar.2018.00257"},{"issue":"10","key":"10.1016\/j.bcp.2020.113860_b0165","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1016\/S0021-9258(18)50710-9","article-title":"Riboflavin and rat hepatic cell structure and function. Mitochondrial oxidative metabolism in deficiency states","volume":"254","author":"Hoppel","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2020.113860_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2014.05.011","article-title":"Hepatic toxicity of dronedarone in mice: role of mitochondrial beta-oxidation","volume":"323","author":"Felser","year":"2014","journal-title":"Toxicology"},{"issue":"27","key":"10.1016\/j.bcp.2020.113860_b0175","doi-asserted-by":"crossref","first-page":"8829","DOI":"10.1007\/s00216-013-7309-z","article-title":"Quantification of plasma carnitine and acylcarnitines by high-performance liquid chromatography-tandem mass spectrometry using online solid-phase extraction","volume":"405","author":"Morand","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2020.113860_b0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cpmo.21","article-title":"Analysis of mtDNA\/nDNA ratio in mice","volume":"7","author":"Quiros","year":"2017","journal-title":"Curr. Protoc. Mouse Biol."},{"issue":"7","key":"10.1016\/j.bcp.2020.113860_b0185","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.bbamcr.2015.03.006","article-title":"Reductive stress impairs myoblasts mitochondrial function and triggers mitochondrial hormesis","volume":"1853","author":"Singh","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.bcp.2020.113860_b0190","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/S0022-2275(20)34939-7","article-title":"Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein","volume":"38","author":"Brasaemle","year":"1997","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.bcp.2020.113860_b0195","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0163-7258(95)00012-6","article-title":"Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity","volume":"67","author":"Fromenty","year":"1995","journal-title":"Pharmacol. Therapeut."},{"issue":"5","key":"10.1016\/j.bcp.2020.113860_b0200","first-page":"1272","article-title":"Mechanisms of impaired hepatic fatty acid metabolism in rats with long-term bile duct ligation","volume":"19","author":"Krahenbuhl","year":"1994","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"2","key":"10.1016\/j.bcp.2020.113860_b0205","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/toxsci\/kfs298","article-title":"Mechanisms of hepatocellular toxicity associated with dronedarone\u2013a comparison to amiodarone","volume":"131","author":"Felser","year":"2013","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2020.113860_b0210","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11010-005-9045-y","article-title":"Analysis of interaction partners for perilipin and ADRP on lipid droplets\u2217","volume":"284","author":"Yamaguchi","year":"2006","journal-title":"Mol. Cellul. Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2020.113860_b0215","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1194\/jlr.M500170-JLR200","article-title":"ADRP\/adipophilin is degraded through the proteasome-dependent pathway during regression of lipid-storing cells","volume":"47","author":"Masuda","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcp.2020.113860_b0220","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.tox.2017.11.013","article-title":"Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction","volume":"393","author":"van Breda","year":"2018","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.bcp.2020.113860_b0225","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.taap.2006.12.016","article-title":"Gene expression profiles of murine fatty liver induced by the administration of valproic acid","volume":"220","author":"Lee","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2020.113860_b0230","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0009-9120(01)00272-7","article-title":"Characterization of plasma acylcarnitines in patients under valproate monotherapy using ESI-MS\/MS","volume":"34","author":"Silva","year":"2001","journal-title":"Clin. Biochem."},{"issue":"4","key":"10.1016\/j.bcp.2020.113860_b0235","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1006\/mgme.2001.3200","article-title":"Valproate induces in vitro accumulation of long-chain fatty acylcarnitines","volume":"73","author":"Silva","year":"2001","journal-title":"Mol. Genet. Metabol."},{"issue":"2","key":"10.1016\/j.bcp.2020.113860_b0240","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0006-2952(92)90298-W","article-title":"Effect of etomoxiryl-CoA on different carnitine acyltransferases","volume":"43","author":"Lilly","year":"1992","journal-title":"Biochem. Pharmacol."},{"issue":"Pt 3","key":"10.1016\/j.bcp.2020.113860_b0245","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1042\/bj3620755","article-title":"Complete beta-oxidation of valproate: cleavage of 3-oxovalproyl-CoA by a mitochondrial 3-oxoacyl-CoA thiolase","volume":"362","author":"Silva","year":"2002","journal-title":"Biochem. J."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2020.113860_b0250","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0009-8981(03)00221-3","article-title":"Direct observation of 3-keto-valproate in urine by 2D-NMR spectroscopy","volume":"334","author":"Meshitsuka","year":"2003","journal-title":"Clin. Chim. Acta; Int. J. Clin. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2020.113860_b0255","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1528-1157.1992.tb02301.x","article-title":"Valproate metabolites in serum and urine during antiepileptic therapy in children with infantile spasms: abnormal metabolite pattern associated with reversible hepatotoxicity","volume":"33","author":"Fisher","year":"1992","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.bcp.2020.113860_b0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005461","article-title":"The promiscuous enzyme medium-chain 3-keto-acyl-CoA thiolase triggers a vicious cycle in fatty-acid beta-oxidation","volume":"13","author":"Martines","year":"2017","journal-title":"PLoS Comput. Biol."},{"issue":"5","key":"10.1016\/j.bcp.2020.113860_b0265","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/ATVBAHA.111.241471","article-title":"Intracellular trafficking and secretion of VLDL","volume":"32","author":"Tiwari","year":"2012","journal-title":"Arterioscl., Thromb., Vascul. Biol."},{"key":"10.1016\/j.bcp.2020.113860_b0270","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev.nutr.27.061406.093710","article-title":"The emerging functions and mechanisms of mammalian fatty acid-binding proteins","volume":"28","author":"Storch","year":"2008","journal-title":"Annu. Rev. Nutrit."},{"issue":"7","key":"10.1016\/j.bcp.2020.113860_b0275","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1074\/jbc.M114.617035","article-title":"Free fatty acids shift insulin-induced hepatocyte proliferation towards CD95-dependent apoptosis","volume":"290","author":"Sommerfeld","year":"2015","journal-title":"J Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2020.113860_b0280","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/hep.20634","article-title":"Mechanisms of benzarone and benzbromarone-induced hepatic toxicity","volume":"41","author":"Kaufmann","year":"2005","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"2","key":"10.1016\/j.bcp.2020.113860_b0285","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00003088-198510020-00003","article-title":"Concentration-effect relationships of valproic acid","volume":"10","author":"Chadwick","year":"1985","journal-title":"Clin. Pharmacok."},{"key":"10.1016\/j.bcp.2020.113860_b0290","doi-asserted-by":"crossref","unstructured":"A. Reimers, J.A. Berg, M.L. Burns, E. Brodtkorb, S.I. Johannessen, C. Johannessen Landmark, Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines, Drug design, development and therapy 12 (2018) 271-280.","DOI":"10.2147\/DDDT.S154388"},{"issue":"1","key":"10.1016\/j.bcp.2020.113860_b0295","article-title":"Comparison of LC-MS\/MS vs chemiluminescent microparticle immunoassay in measuring the valproic acid concentration in plasma of epilepsy patients in a new perspective","volume":"32","author":"Wang","year":"2018","journal-title":"J. Clin. Laborat. Anal."},{"issue":"4","key":"10.1016\/j.bcp.2020.113860_b0300","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/15563650.2017.1284333","article-title":"L-Arginine in the treatment of valproate overdose - five clinical cases, Clinical toxicology","volume":"55","author":"Schrettl","year":"2017","journal-title":"(Philadelphia, Pa.)"},{"key":"10.1016\/j.bcp.2020.113860_bib301","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0076-6879(69)13005-0","article-title":"Citrate synthase","volume":"13","author":"Srere","year":"1969","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bcp.2020.113860_bib302","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1172\/JCI114942","article-title":"Increased hepatic mitochondrial capacity in rats with hydoxy-cobalamin[c-lactam]-induced methylmalonic aciduria","volume":"86","author":"Kr\u00e4henb\u00fchl","year":"1990","journal-title":"J. Clin. Invest."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220300885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220300885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:48:36Z","timestamp":1778629716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220300885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":62,"alternative-id":["S0006295220300885"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.113860","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid affects fatty acid and triglyceride metabolism in HepaRG cells exposed to fatty acids by different mechanisms","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.113860","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113860"}}